New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

May 09, 2023
The British In Vitro Diagnostics Association (BIVDA) commissioned the University of Nottingham to produce an independent White Paper examining the UK Government’s procurement of Covid-19 tests during the pandemic, which has been released today.
Read More
Apr 19, 2023
Digital clinical diagnostics and diabetes home testing provider Digostics and University Hospital Southampton NHS Foundation Trust (UHS) announced today a partnership that will see expectant mothers under the care of UHS maternity services become the first, anywhere in the world, to access ground-breaking new remote testing technology designed to improve screening for gestational diabetes mellitus (GDM).
Read More
Apr 03, 2023
Oxford Cancer Biomarkers Ltd (OCB), a leader in AI-driven, precision cancer diagnostics, has successfully closed its latest investment round.
Read More
Mar 30, 2023
Fast MDx is the first fully automated, high-throughput, near-patient testing system. It can detect many pathogens with unrivalled speed without the need for expensive biosecure laboratories. Developed by London-based social enterprise company Fast MDx, the eponymous testing system cuts the typical 24 to 48 hour waiting time to just one to two hours.
Read More
Mar 29, 2023
The North East Innovation Lab, part of Newcastle Hospitals has achieved a major milestone with accreditation to an international standard. The lab has been awarded accreditation by UKAS to ISO 15189 for SARS-CoV-2 testing which assesses not only the testing carried out by the lab, but also the quality management system required to ensure the laboratory operates to the highest standards.
Read More
Mar 20, 2023
Oxford Cancer Biomarkers (OCB) and OncoHelix today announce a new partnership to offer OCB’s advanced genetic test in Canada for screening and detection of people at risk for colorectal cancer.
Read More
Feb 03, 2023
The Department of Health and Social Care published the first strategy for medical technology today. The British In Vitro Diagnostics Association (BIVDA) welcomes this as another step forward to achieving wider use of the essential diagnostic tests and enabling technology which can really support better healthcare for patients and save resource for the NHS.
Read More
Feb 02, 2023
In this blog, Doris-Ann examines the pandemic’s legacy of normalising diagnostic testing and how we should use this opportunity to be more health aware as a society.
Read More
Jan 30, 2023
Doris-Ann has provided a simple explainer to help companies better understand the NHS Innovation Service and how best to use it.
Read More
Jan 10, 2023
The North East Innovation Lab is celebrating a two-year milestone birthday and has expanded its work in accelerating the development of diagnostics for a range of virus and health threats.
Read More
Page 3 of 34 [3]

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858